Following the "Ryzen AI" rebrand of its mobile APU series, AMD is allegedly altering the naming convention of its Radeon GPUs as the RDNA 4 family is rumored to adopt the RX 9000 moniker ...
Thanks to all the leaks, I thought I knew what to expect with AMD’s upcoming RDNA 4. It turns out I may have been wrong on more than one account. The latest leaks reveal that AMD’s upcoming ...
Rumors around AMD’s next-gen GPUs have gone into overdrive this past weekend, and we’ve learned that these RDNA 4 graphics cards may not be the RX 8000 series as previously thought – and we ...
Rumor mill: AMD appears to be skipping the Radeon RX 8000 nomenclature for its next-gen RDNA 4 GPU lineup. Instead, the successors to the RX 7000 series are expected to be branded as Radeon RX ...
These RDNA 4 cards, part of the Navi 4X series, are expected to be announced at CES 2025. The RX 8600 should easily outperform the current RTX 4060, potentially giving AMD an advantage in the ...
The AYANEO 3 is an upcoming handheld gaming PC with a 7 inch display that looks a lot like previous-generation devices from AYANEO at first glance. But this all-new model has a few significant ...
TL;DR: Rumors suggest Valve may enter the console market with a SteamOS-powered device called "Valve Fremont," potentially competing with PlayStation and Xbox. Discovered changes in the Steam Deck ...
The Radeon RX 7900 GRE, an RDNA 3 graphics card that AMD launched in February to deliver what it says is incredible 1440p/4K gaming, bolstered by advanced features and the latest technology ...
AMD has been playing catchup in the GPU race. However, the upcoming release of the RDNA 4 gives AMD the potential to significantly increase its market share. Earlier this month, a leaker known as ...
Crazy Hero Nat Cancer: The relationship between brain cancer and tissue repair Boehringer Ingelheim discontinues hypertension drug Catapres Cancer also has gender differences: Phf7 protein is the ...
pending chart Removing microRNAs from cancer cells may reverse progression and spread of triple-negative breast cancer Yudao Biotechnology, a company developing allosteric drugs, completes nearly 100 ...